SCHEMBL19704714

SCHEMBL19704714

COC(=O)CCSc1cccc2c1CC(=O)N2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ DHPS P49366 1/20 0.42
▸ DRD2 P14416 7/20 0.41
▸ CDK1 P06493 2/20 0.41
▸ DRD4 P21917 2/20 0.40
▸ DRD3 P35462 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ HTR1A P08908 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ADRA2B P18089 1/20 0.40
▸ DRD1 P21728 1/20 0.40
▸ DRD5 P21918 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11700793 0.82 DRD2 (0.52) DHPSDRD2CDK1DRD4DRD3
SCHEMBL11701831 0.79 DRD2 (0.51) DHPSDRD2CDK1DRD4DRD3
SCHEMBL22493797 0.75 NOTUM (0.41) ALDH1A1KDM4ELMNACYP2C9GSTP1
SCHEMBL9833960 0.74 DRD2 (0.46) DHPSDRD2CDK1DRD4DRD3
SCHEMBL24799999 0.73 GSTP1 (0.36) ALDH1A1HPGDKDM4ECYP3A4CYP2D6
SCHEMBL11700115 0.72 DRD2 (0.50) DRD2CDK1DRD4DRD3KDM4E
SCHEMBL5362141 0.72 CCNB2 (0.48) DHPSDRD2CDK1LMNACCNB2
SCHEMBL10588609 0.71 LMNA (0.47) ALDH1A1HPGDKDM4ELMNAMAPK1
SCHEMBL2116085 0.71 CYP1A2 (0.54) ALDH1A1HPGDKDM4ELMNAMAPK1
SCHEMBL11701011 0.70 KDM4E (0.46) ALDH1A1HPGDDRD2CDK1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464272-B1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO LTD (CN) 2021-12-08 — — EP disclosed
WO-2017211303-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2017-12-14 — — WO disclosed
Send feedback